Among those, C-C chemokine receptor type 5 (CCR5) signaling has been implicated in NAFLD for both parenchymal cells and non-parenchymal cells in the liver [6,7,8]. Here, CCR5 is linked to metabolic dysfunction-associated steatotic liver disease.